Fig. 7From: Suicide gene therapy using allogeneic adipose tissue-derived mesenchymal stem cell gene delivery vehicles in recurrent glioblastoma multiforme: a first-in-human, dose-escalation, phase I clinical trialMR images, including post-gadolinium T1 weighted images and fluid attenuated inversion recovery (FLAIR) at baseline and 12-month after the suicide gene therapy using ADSC vehicles in four patients showing changes in contrast-enhanced tumor (CET) and FLAIR volumesBack to article page